Human Mitogen-Activated Protein Kinase Kinase 2 (MAP2K2) Protein

Product Graph
234€ (1 µg)

Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.

935106861
info@markelab.com
name
Human Mitogen-Activated Protein Kinase Kinase 2 (MAP2K2) Protein
category
Proteins and Peptides
provider
Abbexa
reference
abx073998
tested applications
SDS-PAGE

Description

Human Mitogen-Activated Protein Kinase Kinase 2 Protein is a recombinant protein kinases.

Documents del producto

Instrucciones
Data sheet
Descargar

Product specifications

Category
Proteins and Peptides
Immunogen Target
Mitogen-Activated Protein Kinase Kinase 2 (MAP2K2)
Host
E. coli
Recommended Dilution
Optimal dilutions/concentrations should be determined by the end user.
Origin
Human
Expression
Recombinant
Purity
> 90% (SDS-PAGE)
Size 1
1 µg
Size 2
5 µg
Size 3
50 µg
Form
Liquid 
Tested Applications
SDS-PAGE
Availability
Shipped within 5-10 working days.
Storage
Store at 4 °C if the entire vial will be used within 2-4 weeks. Store at -20 °C for long term storage. For long term storage, it is recommended to add a carrier protein (0.1% HSA or BSA). Avoid repeated freeze/thaw cycles.
Dry Ice
No
UniProt ID
P36507
Background
Protein MAP2K2
Status
RUO
Note
This product is for research use only.   Not for human consumption, cosmetic, therapeutic or diagnostic use.

Descripción

Related Products

EH14912

Human MAP2K2 (Dual specificity mitogen-activated protein kinase kinase 2) ELISA Kit

Ver Producto
FNab05113

MAP2K2 antibody

The protein encoded by this gene is a dual specificity protein kinase that belongs to the MAP kinase kinase family. This kinase is known to play a critical role in mitogen growth factor signal transduction. It phosphorylates and thus activates MAPK1/ERK2 and MAPK2/ERK3. The activation of this kinase itself is dependent on the Ser/Thr phosphorylation by MAP kinase kinase kinases. Mutations in this gene cause cardiofaciocutaneous syndrome (CFC syndrome), a disease characterized by heart defects, mental retardation, and distinctive facial features similar to those found in Noonan syndrome. The inhibition or degradation of this kinase is also found to be involved in the pathogenesis of Yersinia and anthrax. A pseudogene, which is located on chromosome 7, has been identified for this gene.

Ver Producto
FNab10241

MAP2K2 antibody

Ver Producto